Mtv. Chan et al., SINGLE-DOSE PHARMACOKINETICS OF PARACETAMOL AND ITS CONJUGATES IN CHINESE NON-INSULIN-DEPENDENT DIABETIC-PATIENTS WITH RENAL IMPAIRMENT, European Journal of Clinical Pharmacology, 52(4), 1997, pp. 285-288
Objective: A single oral dose of paracetamol (20 mg . kg(-1)) was give
n to 38 Chinese patients with non-insulin-dependent diabetes mellitus
(NIDDM) who had either normal renal function or varying degrees of ren
al impairment, with creatinine clearances ranging from 4 to 123 ml . m
in(-1) 1.73 m(-2). The plasma and urinary concentrations of paracetamo
l and its major metabolites were measured by high-performance liquid c
hromatography (HPLC). Results: The absorption and elimination of parac
etamol were unaffected by renal impairment. However, the area under th
e plasma concentration time curve and the elimination half-life of par
acetamol metabolites increased significantly with worsening renal insu
fficiency. Mean renal clearances of paracetamol and its conjugates wer
e significantly reduced in these subjects. There was no evidence of al
tered metabolic activation with renal impairment. Conclusion: The resu
lts demonstrate that paracetamol disposition is minimally affected by
diabetic nephropathy; however, extensive accumulation of conjugates ma
y occur.